UNDATED (WKRC) - Richard Lassiter, a 44-year-old with a severe peanut allergy, can now eat peanuts daily after participating in a "life-changing" desensitization trial. The trial gradually exposed 18 ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed that only 8.3% of 24 children or adolescents with peanut allergy passed a double-blind ...

Food allergies, immune-mediated adverse reactions to specific foods, have become increasingly prevalent, affecting both children and adults worldwide. Hospital admissions due to food-induced ...

Chicago, IL - Patients who experience hypersensitivity reactions to clopidogrel but who require the drug after having a stent placement can overcome their allergy by undergoing a careful ...

Children with high-threshold peanut allergies may have a new path toward desensitization through a simple and inexpensive method. A recent study suggests that gradually increasing daily doses of store ...

Researchers have developed an alternative way of desensitizing very young peanut-allergic children to the food. Under-the-tongue immunotherapy was found to be safer and easier to administer than the ...

ATLANTA - If you have to be vigilant about what you eat, and keep an EpiPen close, Dr. Tom Chacko of Chacko Allergy, Asthma and Sinus Center, says the newly FDA-authorized allergy medication, Xolair, ...

If you could treat your peanut allergy while brushing your teeth, that would be a win-win situation, right? Well, it might soon be possible. Introducing small amounts of peanut orally and over time ...

NEW YORK (Reuters Health) - Children who have a potentially life-threatening allergy to cow's milk can often "learn" to tolerate milk through a carefully orchestrated, supervised program in which they ...

A clinical study led by Edwin Kim, MD, at the UNC School of Medicine, showed how Peanut Sublingual Immunotherapy (Peanut SLIT) is safe and effective in children ranging from 1-to-4 years of age.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window New consensus ...